13 completed. 13 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 13 | Completed 13 |
| Phase 1 | 1 | Completed 1 |
Follow Mr Imaging: new trials by email Literature Review of Mr Imaging trials Research Report on Mr Imaging
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate Cancer Biopsy, Biospecimen Collection, Computed Tomography - Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 | Phase 2 | Completed | Mayo Clinic | 7 | 2024-03-08 | 2026-06-09 |
| Lifileucel With Reduced Dose Fludarabine/Cyclophosphamide Lymphodepletion and Interleukin-2 for the Treatment of Patients With Unresectable or Metastatic Melanoma Biospecimen Collection, Cyclophosphamide, Echocardiography - Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma | Phase 2 | Completed | University of Kansas Medical Center | 11 | 2023-12-21 | 2026-04-30 |
| 68Ga-PSMA-Dual-Contrast PET/MRI or PET/CT for Early Detection of Liver Cancer Computed Tomography, Gallium Ga 68 Gozetotide, Magnetic Resonance Imaging - Hepatocellular Carcinoma | Phase 2 | Completed | Mayo Clinic | 52 | 2021-02-24 | 2026-08-12 |
| Berzosertib and Irinotecan in Treating Patients With Progressive, Metastatic, or Unresectable TP53 Mutant Gastric or Gastroesophageal Junction Cancer Berzosertib, Computed Tomography Assisted Biopsy, Endoscopic Biopsy - Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Phase 2 | Completed | National Cancer Institute (NCI) | 17 | 2020-11-16 | 2026-10-20 |
| Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma Atezolizumab, Biopsy, Biospecimen Collection - Advanced Bladder Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 47 | 2019-06-05 | 2024-07-26 |
| 18F-DOPA-PET/MRI Scan in Imaging Elderly Patients With Newly Diagnosed Grade IV Malignant Glioma or Glioblastoma During Planning for a Short Course of Proton Beam Radiation Therapy Computed Tomography, Fluorodopa F 18, Magnetic Resonance Imaging - Glioblastoma, Malignant Glioma | Phase 2 | Completed | Mayo Clinic | 43 | 2019-03-28 | 2025-07-03 |
| Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer Atezolizumab, Biopsy, Biospecimen Collection - Gallbladder Carcinoma, Metastatic Cholangiocarcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 86 | 2018-02-08 | 2024-04-05 |
| Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial) Biospecimen Collection, Computed Tomography, FDG-Positron Emission Tomography - Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Non-Hodgkin Lymphoma | Phase 2 | Completed | National Cancer Institute (NCI) | 18 | 2017-11-28 | 2026-04-21 |
| TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer Anastrozole, Denifanstat, Exemestane - Advanced Breast Carcinoma, HER2-Positive Breast Carcinoma | Phase 2 | Completed | Mayo Clinic | 17 | 2017-08-03 | 2026-10-09 |
| Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging - Cirrhosis, Hepatocellular Carcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 52 | 2017-06-21 | 2026-09-09 |
| Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement Azacitidine, Biospecimen Collection, Computed Tomography - Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia | Phase 2 | Completed | National Cancer Institute (NCI) | 78 | 2017-04-01 | 2025-02-27 |
| Uprosertib, Dabrafenib, and Trametinib in Treating Patients With Stage IIIC-IV Cancer Biopsy, Biospecimen Collection, Computed Tomography - Hematopoietic and Lymphoid Cell Neoplasm, Locally Advanced Malignant Solid Neoplasm | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 27 | 2013-10-08 | 2025-01-14 |
| Veliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast Cancer Biopsy, Biospecimen Collection, Carboplatin - Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 | Phase 2 | Completed | National Cancer Institute (NCI) | 77 | 2010-06-30 | 2025-08-15 |
Carcinoma, Hepatocellular (2) · Glioma (2) · Melanoma (2) · Breast Neoplasms (1) · Burkitt Lymphoma (1) · Carcinoma, Transitional Cell (1) · Central Nervous System Neoplasms (1) · Cholangiocarcinoma (1) · Ependymoma (1) · Fibrosis (1) · Gallbladder Neoplasms (1) · Glioblastoma (1) · Hematologic Neoplasms (1) · Hepatoblastoma (1) · Histiocytosis, Langerhans-Cell (1)
National Cancer Institute (NCI) (8) · Mayo Clinic (4) · University of Kansas Medical Center (1)
United States (13) · Puerto Rico (3) · Canada (2) · Australia (1)
Ajit H. Goenka, M.D. (1) · Antoni Ribas (1) · Evan Y Yu (1) · Jacob Orme, M.D., Ph.D. (1) · Joanne Mortimer (1) · Jordan D Berlin (1) · Marc T Goodman (1) · Muhammad Umair Mushtaq (1) · Nilofer S Azad (1) · Rishi S Kotecha (1) · Sujay A Vora (1) · Theodore W Laetsch (1) · Tufia C. Haddad, M.D. (1)
PMID 31401903, PMID 33084020, PMID 34783177, PMID 34907910, PMID 38261444, PMID 38867582, PMID 39571596, PMID 40343719, PMID 41335461
U10CA180886 (2), N01CM00032 (1), N01CM00038 (1), N01CM00039 (1), N01CM00071 (1), N01CM00099 (1), N01CM62201 (1), N01CM62202 (1), N01CM62203 (1), N01CM62209 (1), N01CN00035 (1), P30CA015704 (1), P30CA033572 (1), P30CA060553 (1), P30CA168524 (1)